The firm's technology uses DNA sequencing, artificial intelligence, and a microbial database to interpret soil health and identify potential disease risk.
The firm has been piecing together a collection of acquisitions over recent years that expand its presence in the genomics market, particularly custom oligos.
Syngenta will be able to use the platform to evaluate, predict, compare, and select the best genetic makeup for crop molecular breeding and genomic selection.
At the Plant and Animal Genome conference, a Danish researcher shared results from a SNP analysis of ancient grape seeds going back to the Medieval Period.
In an editorial, officials from scientific societies in the US and China call for the international community to develop criteria and standards for human germline editing.
The US National Institutes of Health is to review studies that have received private support for conflicts of interest, according to the New York Times.
